2018
DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Additional Lipid-Lowering Therapy on New Ischemic Lesions of Diffusion-Weighted Imaging in Carotid Artery Stenting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 28 publications
0
4
0
1
Order By: Relevance
“…37 Statins are effective in preventing periprocedural complications 38,39 and in reducing brain lesions detected with magnetic resonance imaging diffusion-weighted image after CAS. 40 Short-term statin loading before CAS also reduced the incidence of 30-day ischemic cerebral events. 41 Recently, a systemic review covered the topic of carotid artery stenting and statin loading and summarized the beneficial effect of statin therapy in patients with CAS.…”
Section: Discussionmentioning
confidence: 96%
“…37 Statins are effective in preventing periprocedural complications 38,39 and in reducing brain lesions detected with magnetic resonance imaging diffusion-weighted image after CAS. 40 Short-term statin loading before CAS also reduced the incidence of 30-day ischemic cerebral events. 41 Recently, a systemic review covered the topic of carotid artery stenting and statin loading and summarized the beneficial effect of statin therapy in patients with CAS.…”
Section: Discussionmentioning
confidence: 96%
“…40 Administration of additional pre-procedural anticoagulants and additional lipid lowering therapy may be protective for development of new DWI lesions. 35,36,41 Another topic of interest is procedural timing in symptomatic patients. 37 As cerebrovascular events are more likely to occur in patients with unstable plaque, one could rationalise that timing of the procedure in symptomatic patients may influence the chance of dislodgement of plaque debris and therefore new DWI lesions, in line with research suggesting increased stroke risk after very urgent CEA.…”
Section: Discussionmentioning
confidence: 99%
“…53 The addition of a PCSK9 inhibitor to statin therapy appears to have a beneficial effect in patients undergoing CAS. 54 Patients initiated on a PCSK9 inhibitor (besides their standard statin treatment) before undergoing CAS had a significant reduction in new ischemic lesions on diffusion-weighted imaging compared with patients only receiving standard statin treatment (11.5 vs 41.2%, respectively; p = 0.029). 54 Preliminary evidence suggests that preoperative administration of PCSK9 inhibitors stabilize carotid plaques and reduce perioperative complications in patients undergoing CAS.…”
Section: Drawbacks Associated With Statin Usementioning
confidence: 91%
“…54 Patients initiated on a PCSK9 inhibitor (besides their standard statin treatment) before undergoing CAS had a significant reduction in new ischemic lesions on diffusion-weighted imaging compared with patients only receiving standard statin treatment (11.5 vs 41.2%, respectively; p = 0.029). 54 Preliminary evidence suggests that preoperative administration of PCSK9 inhibitors stabilize carotid plaques and reduce perioperative complications in patients undergoing CAS. 55 The beneficial effects of PCSK9 inhibitors on carotid plaque composition and regression will be investigated in the on-going CARotid plaqUe StabilizatiOn and regression with evolocumab (CARUSO) study.…”
Section: Drawbacks Associated With Statin Usementioning
confidence: 91%